Clinical Trial Update: A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a PD-1 inhibitor in combination with denosumab and chemotherapy for locally advanced or metastatic non-squamous non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Denosumab (denosumab)
• PD-1 inhibitor

Snippet

Sponsor: China Medical University, China | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: RECRUITING